← FDA DRUG APPROVALS

FDA ANDA · ANDA087546

HYDROXYZINE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA087546
TYPE
ANDA
ORIGINAL APPROVAL
1981-06-15
LATEST ACTION
2001-02-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HYDROXYZINE HYDROCHLORIDEDiscontinued
HYDROXYZINE HYDROCHLORIDE 50MG/ML · INJECTABLE · INJECTION

Approval history

2001-02-14Manufacturing (CMC) · Supplement 10AP
1995-12-22Manufacturing (CMC) · Supplement 9AP
1991-07-19Labeling · Supplement 7AP
1989-12-26Manufacturing (CMC) · Supplement 4AP
1989-12-26Manufacturing (CMC) · Supplement 5AP
1989-09-12Labeling · Supplement 6AP
1989-07-31Labeling · Supplement 3AP
1981-06-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →